Cargando…
Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
BACKGROUND: Very scanty evidence is available on factors influencing the choice of immunosuppressive drug therapy after kidney transplantation. METHODS: An Italian multiregional real-world study was conducted integrating national transplant information system and claims data. All patients undergoing...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604923/ https://www.ncbi.nlm.nih.gov/pubmed/37891504 http://dx.doi.org/10.1186/s12882-023-03325-9 |
_version_ | 1785126950874906624 |
---|---|
author | Rosa, Alessandro C. Finocchietti, Marco Agabiti, Nera Menè, Paolo Bracaccia, Maria Elena Bellini, Arianna Massari, Marco Spila Alegiani, Stefania Masiero, Lucia Bedeschi, Gaia Cardillo, Massimo Lucenteforte, Ersilia Piccolo, Giuseppe Leoni, Olivia Ferroni, Eliana Pierobon, Silvia Nordio, Maurizio Ledda, Stefano Garau, Donatella Davoli, Marina Addis, Antonio Belleudi, Valeria |
author_facet | Rosa, Alessandro C. Finocchietti, Marco Agabiti, Nera Menè, Paolo Bracaccia, Maria Elena Bellini, Arianna Massari, Marco Spila Alegiani, Stefania Masiero, Lucia Bedeschi, Gaia Cardillo, Massimo Lucenteforte, Ersilia Piccolo, Giuseppe Leoni, Olivia Ferroni, Eliana Pierobon, Silvia Nordio, Maurizio Ledda, Stefano Garau, Donatella Davoli, Marina Addis, Antonio Belleudi, Valeria |
author_sort | Rosa, Alessandro C. |
collection | PubMed |
description | BACKGROUND: Very scanty evidence is available on factors influencing the choice of immunosuppressive drug therapy after kidney transplantation. METHODS: An Italian multiregional real-world study was conducted integrating national transplant information system and claims data. All patients undergoing kidney transplantation for the first time during 2009–2019 (incident patients) were considered. Multilevel logistic models were used to estimate Odds Ratio (OR) and corresponding 95% Confidence intervals. Factors with statistically significance were identified as characteristics associated with treatment regimens: cyclosporin-CsA vs tacrolimus-Tac and, within the latter group, mTOR inhibitors vs mycophenolate-MMF. RESULTS: We identified 3,622 kidney patients undergoing transplantation in 17 hospitals located in 4 Italian regions, 78.3% was treated with TAC-based therapy, of which 78% and 22% in combination with MMF and mTOR, respectively. For both comparison groups, the choice of immunosuppressive regimens was mostly guided by standard hospital practices. Only few recipient and donor characteristics were found associated with specific regimen (donor/receipt age, immunological risk and diabetes). CONCLUSIONS: The choice of post-renal transplant immunosuppressive therapy seems to be mostly driven by standard Centre practices, while only partially based on patient’s characteristics and recognized international guidelines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03325-9. |
format | Online Article Text |
id | pubmed-10604923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106049232023-10-28 Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) Rosa, Alessandro C. Finocchietti, Marco Agabiti, Nera Menè, Paolo Bracaccia, Maria Elena Bellini, Arianna Massari, Marco Spila Alegiani, Stefania Masiero, Lucia Bedeschi, Gaia Cardillo, Massimo Lucenteforte, Ersilia Piccolo, Giuseppe Leoni, Olivia Ferroni, Eliana Pierobon, Silvia Nordio, Maurizio Ledda, Stefano Garau, Donatella Davoli, Marina Addis, Antonio Belleudi, Valeria BMC Nephrol Research BACKGROUND: Very scanty evidence is available on factors influencing the choice of immunosuppressive drug therapy after kidney transplantation. METHODS: An Italian multiregional real-world study was conducted integrating national transplant information system and claims data. All patients undergoing kidney transplantation for the first time during 2009–2019 (incident patients) were considered. Multilevel logistic models were used to estimate Odds Ratio (OR) and corresponding 95% Confidence intervals. Factors with statistically significance were identified as characteristics associated with treatment regimens: cyclosporin-CsA vs tacrolimus-Tac and, within the latter group, mTOR inhibitors vs mycophenolate-MMF. RESULTS: We identified 3,622 kidney patients undergoing transplantation in 17 hospitals located in 4 Italian regions, 78.3% was treated with TAC-based therapy, of which 78% and 22% in combination with MMF and mTOR, respectively. For both comparison groups, the choice of immunosuppressive regimens was mostly guided by standard hospital practices. Only few recipient and donor characteristics were found associated with specific regimen (donor/receipt age, immunological risk and diabetes). CONCLUSIONS: The choice of post-renal transplant immunosuppressive therapy seems to be mostly driven by standard Centre practices, while only partially based on patient’s characteristics and recognized international guidelines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03325-9. BioMed Central 2023-10-27 /pmc/articles/PMC10604923/ /pubmed/37891504 http://dx.doi.org/10.1186/s12882-023-03325-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Rosa, Alessandro C. Finocchietti, Marco Agabiti, Nera Menè, Paolo Bracaccia, Maria Elena Bellini, Arianna Massari, Marco Spila Alegiani, Stefania Masiero, Lucia Bedeschi, Gaia Cardillo, Massimo Lucenteforte, Ersilia Piccolo, Giuseppe Leoni, Olivia Ferroni, Eliana Pierobon, Silvia Nordio, Maurizio Ledda, Stefano Garau, Donatella Davoli, Marina Addis, Antonio Belleudi, Valeria Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) |
title | Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) |
title_full | Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) |
title_fullStr | Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) |
title_full_unstemmed | Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) |
title_short | Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) |
title_sort | determinants of immunosuppressive therapy in renal transplant recipients: an italian observational study (the cesit project) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604923/ https://www.ncbi.nlm.nih.gov/pubmed/37891504 http://dx.doi.org/10.1186/s12882-023-03325-9 |
work_keys_str_mv | AT rosaalessandroc determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT finocchiettimarco determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT agabitinera determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT menepaolo determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT bracacciamariaelena determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT belliniarianna determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT massarimarco determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT spilaalegianistefania determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT masierolucia determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT bedeschigaia determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT cardillomassimo determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT lucenteforteersilia determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT piccologiuseppe determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT leoniolivia determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT ferronieliana determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT pierobonsilvia determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT nordiomaurizio determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT leddastefano determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT garaudonatella determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT davolimarina determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT addisantonio determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT belleudivaleria determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject AT determinantsofimmunosuppressivetherapyinrenaltransplantrecipientsanitalianobservationalstudythecesitproject |